BrainsWay to Participate in the Citi 2026 Unplugged MedTech and Life Sciences Access Day

BrainsWay (NASDAQ: BWAY) announced management will hold one-on-one meetings at the Citi 2026 Unplugged MedTech and Life Sciences Access Day on Thursday, February 26, 2026, in New York.

Rhea-AI Summary

BrainsWay (NASDAQ: BWAY) announced management will hold one-on-one meetings at the Citi 2026 Unplugged MedTech and Life Sciences Access Day on Thursday, February 26, 2026, in New York. Investors or analysts should contact their Citi representative to request a meeting.

Market Context

This announcement highlights upcoming one-on-one investor meetings at a MedTech and life sciences ev...

Analysis

This announcement highlights upcoming one-on-one investor meetings at a MedTech and life sciences event on February 26, 2026, adding to a busy stretch of corporate updates. Recent history featured payer coverage decisions, an ADS ratio change, an FDA device approval, and a minority investment. Investors focusing on this name often monitor how such visibility events complement reimbursement progress and product adoption milestones.

Key Figures

Conference date: February 26, 2026

Conference date

February 26, 2026

Citi 2026 Unplugged MedTech and Life Sciences Access Day

Historical Context

5 past events · Latest: Feb 19

5 events

1. Feb 19

   Minority-stake investment

   24h Move

   -7.5%

   Announced staged minority equity investment in BrainStim Health with milestone tranches.

2. Feb 18

   Coverage expansion

   24h Move

   +4.3%

   Evernorth Behavioral Health removed prior authorization for TMS coverage.

3. Feb 17

   ADS ratio change

   24h Move

   +8.6%

   Changed ADS-to-ordinary share ratio to 1-to-1, a 2-for-1 ADS split.

4. Jan 21

   Coverage policy draft

   24h Move

   +4.7%

   Highmark draft policy expanding coverage for accelerated Deep TMS protocol.

5. Jan 12

   FDA device approval

   24h Move

   +4.7%

   FDA PMA approval for Proliv™Rx at-home neuromodulation system for MDD.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BURLINGTON, Mass. and JERUSALEM, Feb. 23, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today announced that management will participate in one-on-one meetings at the Citi 2026 Unplugged MedTech and Life Sciences Access Day on Thursday, February 26, 2026, in New York, NY.

Please contact your Citi representative to request a meeting at the conference.

About BrainsWay
BrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders. The Company is boldly advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) platform technology to improve health and transform lives. BrainsWay is the first and only TMS company to obtain three FDA-cleared indications backed by pivotal clinical studies demonstrating clinically proven efficacy. Current indications include major depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. The Company is dedicated to leading through superior science and building on its unparalleled body of clinical evidence. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. Founded in 2003, with operations in the United States and Israel, BrainsWay is committed to increasing global awareness of and broad access to Deep TMS. For the latest news and information about BrainsWay, please visit www.brainsway.com.

Contacts:
BrainsWay:
Ido Marom
Chief Financial Officer
Ido.Marom@BrainsWay.com

Investors:
Brian Ritchie
LifeSci Advisors
britchie@lifesciadvisors.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will BrainsWay (BWAY) participate in the Citi 2026 Unplugged MedTech and Life Sciences Access Day?

BrainsWay management will participate on Thursday, February 26, 2026 in New York City. According to the company, management will conduct one-on-one meetings at the event to engage with investors and analysts and discuss company developments.

How can investors request a meeting with BrainsWay (BWAY) at the Citi 2026 Access Day?

Investors should contact their Citi representative to request a meeting with BrainsWay management. According to the company, meeting requests are facilitated through Citi and interested parties should coordinate directly with their Citi contact prior to the event date.

What topics will BrainsWay (BWAY) management likely cover at the Citi 2026 Unplugged event?

Management will likely discuss corporate strategy, product portfolio, and market developments with attendees. According to the company, one-on-one meetings are intended for investor engagement and may cover recent business highlights and forward-looking priorities.

Where is the Citi 2026 Unplugged MedTech and Life Sciences Access Day taking place for BrainsWay (BWAY)?

The event takes place in New York, NY on February 26, 2026. According to the company, BrainsWay management will be available for scheduled one-on-one meetings at the Citi-hosted access day in New York City.

Will BrainsWay (BWAY) provide a public presentation at the Citi 2026 Unplugged MedTech and Life Sciences Access Day?

BrainsWay announced one-on-one meetings but did not mention a public presentation. According to the company, management will participate in one-on-one sessions, and investors should contact Citi for meeting availability and format details.